NCT04380779已完成不适用
Prevalence of Severe Bleeding in COVID-19 Patients Treated With Higher Than Recommended Thromboprophylaxis Doses (BLEEDING Study)
Manuel Monreal1 个研究点 分布在 1 个国家目标入组 2,430 人开始时间: 2020年4月13日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 2,430
- 试验地点
- 1
- 主要终点
- Bleeding events and complications
研究概览
简要总结
The main objectives are:
- To establish the prevalence of major bleeding in patients treated with higher than recommended thromboprophylaxis doses.
- To identify variables associated to higher risk of bleeding.
研究设计
- 研究类型
- Observational
- 观察模型
- Other
- 时间视角
- Retrospective
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients infected with COVID-19 treated with higher than recommended thromboprophylaxis doses.
- •Admission to hospital.
排除标准
- •Patients treated with ECMO (Extracorporeal membrane oxygenation).
结局指标
主要结局
Bleeding events and complications
时间窗: 30 days
Study endpoints are clinically recognized (and objectively confirmed) major and minor bleeding complications, and death.
次要结局
未报告次要终点
研究者
Manuel Monreal
Professor of Internal Medicine
Foundation for the study of VTE diseases. (FUENTE)
研究点 (1)
Loading locations...
相似试验
Unknown
不适用
Study of Hemostasis in Case of Severe COVID-19COVID-19 InfectionNCT04359992University Hospital, Strasbourg, France50
招募中
不适用
Incidence of Severe COVID-19 Infection in Patients With CLL or B-NHL Who Received Pre-exposure Prophylaxis With Tixagevimab and Cilgavimab in Italy.Indolent B-Cell Non-Hodgkin LymphomaCOVID-19Chronic Lymphocytic LeukemiaNCT05803395Gruppo Italiano Malattie EMatologiche dell'Adulto954
招募中
不适用
Covid-19 in Hematological MalignanciesCOVID-19 Infection in Hematological Malignancies PatientsNCT04733729Sorveglianza Epidemiologica Infezioni Fungine Emopatie Maligne3,000
已完成
不适用
Blood Coagulation Abnormalities in COVID-19 (Corona Virus Disease-19) PatientsCovid19NCT04982263Sohag University125
终止
2 期
Enzalutamide Treatment in COVID-19COVID-19Corona Virus InfectionNCT04475601Andreas Josefsson42